Patent details

EP2279261 Title: IN VITRO ESTIMATION OF IN VIVO HALF-LIFE BINDING PROTEINS

Basic Information

Publication number:
EP2279261
PCT Application Number:
PCT/US/2009/002384
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097328199
PCT Publication Number:
WO/2009/128931
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IN VITRO ESTIMATION OF IN VIVO HALF-LIFE BINDING PROTEINS
French Title of Invention:
ESTIMATION IN VITRO DE LA DEMI-VIE IN VIVO DE PROTÉINES DE LIAISON
German Title of Invention:
IN-VITRO-ABSCHÄTZUNG DER IN-VIVO-HALBWERTSZEIT VON BINDUNGSPROTEINEN
SPC Number:

Dates

Filing date:
16/04/2009
Grant date:
27/08/2014
EP Publication Date:
27/08/2014
PCT Publication Date:
22/10/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/02/2011
EP B1 Publication Date:
27/08/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/04/2015
Expiration date:
16/04/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/04/2009
 
 

Name:
AbbVie Inc.
Address:
1 North Waukegan Road, North Chicago, IL 60064, United States (US)

Inventor

Name:
TALANIAN Robert, V.
Address:
United States (US)

Priority

Priority Number:
46062 P
Priority Date:
18/04/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
C12Q 1/34;
Filing date Document type Number of pages